MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$101,290K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Revenue
Deferred revenue
Maturities of marketable securit...
Others
Negative Cash Flow Breakdown
Sales and marketing
Purchases of marketable securiti...
Deferred commissions
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
212,817
182,307
587,860
-
Excess and obsolete inventory charge
-
-
0
-
Restructuring, acquisition and other expenses
-
-
5,351
-
Acquisition and other expenses
440
694
-
-
Stock-based compensation expense
19,092
11,692
643,009
-
Other segment income
-1,710
-1,350
-644
-
Cost of revenue
27,471
26,907
98,735
-
Research and development
25,908
25,539
89,709
-
Sales and marketing
75,071
64,389
207,890
-
General and administrative
22,855
19,308
72,071
-
Net income (loss)
43,690
35,128
32,095
-560,356
Depreciation and amortization
1,061
1,173
1,223
3,910
Stock-based compensation
19,092
11,692
17,172
625,837
Amortization of deferred commissions
19,085
16,205
14,231
32,436
Accretion of discounts and amortization of premiums on marketable securities, net
-569
-135
15
-376
Excess and obsolete inventory charge
-
-
0
-
Non-cash operating lease expense
929
905
882
2,549
Provision for credit losses
1,613
0
-279
3,340
Deferred income taxes
13
0
-93
146
Other
1
0
1
-2
Accounts receivable
12,124
48,860
-20,983
47,610
Deferred commissions
-28,476
-20,603
-25,259
-38,320
Inventory
2,602
-1,470
1,824
2,939
Prepaid expenses and other current assets
7,730
3,590
7,773
8,002
Other assets
-331
658
-7,968
8,149
Accounts payable and accrued liabilities
-8,654
11,246
4,417
24,990
Operating lease liabilities
-1,084
-1,070
-995
-2,724
Deferred revenue
75,701
39,910
1,161
82,062
Net cash provided by operating activities
101,413
43,083
63,893
107,548
Purchase of property and equipment
123
83
408
300
Capitalized internal use software
1,731
1,447
1,955
3,401
Purchases of marketable securities
30,921
58,956
154,108
318,180
Maturities of marketable securities
61,393
108,567
118,775
249,814
Acquisition of a business
0
0
0
4,000
Net cash provided by (used in) investing activities
28,618
48,081
-37,696
-76,067
Proceeds from exercise of common stock options
270
410
629
787
Issuance of common stock in connection with the employee stock purchase plan
7,276
-
8,113
-
Proceeds from issuance of common stock in initial public offering, net of issuance costs
0
-
0
255,675
Repurchase and retirement of common stock
26,525
104,966
65,028
-
Tax withholdings on settlement of restricted stock units and performance-based restricted stock units
11,499
8,292
22,971
272,258
Payment on repurchase agreement with coatue
0
-
0
50,000
Cash paid on settlement of acquisition related holdback
-
-
0
-
Proceeds from repayment of non-recourse loans to employees
0
0
0
4,934
Payments for deferred offering costs
0
0
288
10,061
Net cash used in financing activities
-30,478
-112,848
-79,545
-70,923
Net increase (decrease) in cash, cash equivalents, and restricted cash
99,553
-21,684
-53,348
-39,442
Cash, cash equivalents and restricted cash, beginning of period
188,112
209,796
238,972
238,972
Cash, cash equivalents and restricted cash, end of period
287,665
-
-
-
Cash and cash equivalents
286,224
-
-
-
Restricted cash
1,441
-
-
-
Total cash, cash equivalents, and restricted cash
287,665
188,112
209,796
263,144
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Revenue
$212,817K
Other segment income
-$1,710K
Deferred revenue
$75,701K
Net income (loss)
$43,690K
Maturities of marketable
securities
$61,393K
Stock-based compensation
$19,092K
Amortization of deferred
commissions
$19,085K
Provision for credit
losses
$1,613K
Depreciation and
amortization
$1,061K
Non-cash operating lease
expense
$929K
Accretion of discounts and
amortization of premiums on...
-$569K
Other assets
-$331K
Deferred income taxes
$13K
Canceled cashflow
$170,837K
Net cash provided by
operating activities
$101,413K
Net cash provided by
(used in) investing...
$28,618K
Canceled cashflow
$60,671K
Canceled cashflow
$32,775K
Sales and marketing
$75,071K
Cost of revenue
$27,471K
Research and development
$25,908K
General and
administrative
$22,855K
Stock-based compensation
expense
$19,092K
Acquisition and other
expenses
$440K
Net increase
(decrease) in cash, cash...
$99,553K
Canceled cashflow
$30,478K
Deferred commissions
-$28,476K
Accounts receivable
$12,124K
Accounts payable and
accrued liabilities
-$8,654K
Prepaid expenses and
other current assets
$7,730K
Inventory
$2,602K
Operating lease
liabilities
-$1,084K
Other
$1K
Issuance of common stock
in connection with...
$7,276K
Proceeds from exercise of
common stock options
$270K
Purchases of marketable
securities
$30,921K
Capitalized internal use
software
$1,731K
Purchase of property and
equipment
$123K
Net cash used in
financing activities
-$30,478K
Canceled cashflow
$7,546K
Repurchase and retirement
of common stock
$26,525K
Tax withholdings on
settlement of restricted...
$11,499K
Buy us a coffee
Hinge Health, Inc. (HNGE)
Hinge Health, Inc. (HNGE)